ACCOLADE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.54 USD | +3.86% |
|
-4.44% | -37.22% |
| 04-30 | Wells Fargo Cuts Price Target on Accolade to $10 From $12, Maintains Equalweight Rating | MT |
| 04-26 | Morgan Stanley Trims Accolade's Price Target to $12 From $13, Maintains Equal Weight Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Healthcare Facilities & Services
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 569M | - | |||||
| 81.68B | ||||||
| 69.23B | ||||||
| 29.08B | ||||||
| 16.88B | ||||||
| 16.85B |
- Stock Market
- Equities
- ACCD Stock
- Charts Accolade, Inc.
- Sector Chart
